PaxMedica, Inc. (PXMD) Stock Statistics & Valuation Metrics

PaxMedica, Inc. has a market cap or net worth of $1.53M. The enterprise value is ―.

PaxMedica, Inc. has 126,264,370 shares outstanding. The number of shares has decreased by -2.65% in one year.

PaxMedica, Inc.’s return on equity (ROE) is -5.40 and return on invested capital (ROIC) is -415.56%.

The current PE Ratio of PaxMedica, Inc. is ―. PaxMedica, Inc.’s PEG ratio is 0.00112.

In the last 12 months, PaxMedica, Inc. had revenue of 0.00 and earned -18.29M in profits. Earnings per share was -11.00.

In the last 12 months, operating cash flow was -9.32M and capital expenditures 0.00, giving a free cash flow of -9.32M billion.

PaxMedica, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

PaxMedica, Inc. upcoming earnings date is Nov 13, 2024, Before Open (Confirmed).

PaxMedica, Inc. as a current ratio of 3.16, with Debt / Equity ratio of 0.00%

In the past 12 months, PaxMedica, Inc. has paid 0.00 in taxes.

PaxMedica, Inc. EV to EBITDA ratio is 0.21, with an EV/FCF ratio of 0.32.

PaxMedica, Inc. has $324.49K in cash and marketable securities with $0.00 in debt, giving a net cash position of $324.49K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for PaxMedica, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―